TUESDAY, Nov. 19, 2024 (HealthDay News) — People using blood thinners to control their heart rhythm shouldn’t expect the medications to head off thinking declines as well, new research suggests. The study, presented Saturday at a meeting of the American Heart Association in Chicago, is the first large trial toContinue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain toContinue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing schizophrenia compared to the general population, Canadian researchers report. EvenContinue Reading